Phytocannabinoids in the treatment of cancer
US9675654B2 · kind B2 · utility
13Cited by
4References
1Claims
0Family size
Assignees
Inventors
- Daniela Parolaro
- Paola Massi
- Angelo Antonio Izzo
- Francesca Borrelli
- Gabriella Aviello
- Vincenzo Di Marzo
- Luciano De Petrocellis
- Aniello Schiano Moriello
- Alessia Ligresti
- Ruth Alexandra Ross
- Lesley Ann Ford
- Sharon Anavi-Goffer
- Manuel Guzman
- Guillermo Velasco
- Mar Lorente
- Sofia Torres
- Tetsuro Kikuchi
- Geoffrey Guy
- Colin Stott
- Stephen Wright
- Alan Sutton
- David A. Potter
- Etienne De Meijer
Key dates
| Filing date | Apr 24, 2014 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | May 7, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of phytocannabinoids, either in an isolated form or in the form of a botanical drug substance (BDS) in the treatment of cancer. Preferably the cancer to be treated is cancer of the prostate, cancer of the breast or cancer of the colon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.